-
PPD Awarded U.S. Army Contract with Ceiling Value of $45.5M
Tuesday, May 31, 2011 - 4:51pm | 73PPD, Inc. (Nasdaq: PPDI) today announced it has been awarded the U.S. Army Medical Research Acquisition Activity: Regulatory Affairs & Compliance Support contract to provide global regulatory and biostatistical services for a range of clinical development programs funded by the U.S. Army. The...
-
Calls Purchased on BioDelivery Sciences International
Tuesday, May 31, 2011 - 10:47am | 131Shares of BioDelivery Sciences International (NASDAQ: BDSI) are lower on the session by 0.30%, currently trading at $3.27. The stock has been moving largely lower over the past three months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying calls on...
-
Morgan Stanley Provides Color on Illumina, Overweight
Tuesday, May 31, 2011 - 9:10am | 161Morgan Stanley provided color on Illumina (NASDAQ: ILMN) after meeting the company's CEO Jay Flatley. In a research report published today, Morgan Stanley maintained its optimism about the company's long-term prospects. In the report, Morgan Stanley states, "Early MiSeq orders appear to be...
-
Genetic Technologies Processes First BREVAGen Patient Sample
Tuesday, May 31, 2011 - 8:57am | 114Genetic Technologies Limited (NASDAQ: GENE) has received and processed its first BREVAGen™ clinical sample from a US patient. This follows last month's receipt of certification of its Australian laboratory under the US Clinical Laboratories Improvements Amendments. The sample was received by...
-
Benzinga's Top Upgrades
Tuesday, May 31, 2011 - 8:10am | 144Robert W. Baird upgraded AMAG Pharmaceuticals Inc (NASDAQ: AMAG) from “neutral” to “outperform.” AMAG's shares closed at $16.80 yesterday. AMAG Pharmaceuticals had $238.23 million in total cash for the latest quarter. Citigroup upgraded Mosaic Company (NYSE: MOS) from “hold” to “buy.” MOS' shares...
-
Goldman Sachs PT Changes For 5/31
Tuesday, May 31, 2011 - 7:59am | 145Goldman Sachs has changed the price targets on the following companies: Affymetrix (NASDAQ: AFFX) from $4.50 to $5, Sell Bank of New York Mellon (NYSE: BK) from $30 to $29, Neutral Baxter International (NYSE: BAX) from $69 to $72, Buy CME Group (NASDAQ: CME) from $345 to $325, Neutral...
-
Jefferies Comments on "Encouraging" Thermo Fisher Outlook
Friday, May 27, 2011 - 7:47am | 116Thermo Fisher Scientific, Inc.'s (NYSE: TMO) initial 2012 core operating outlook and longer-term base operating model parameters “remain largely consistent with goals communicated in prior forums historically,” Jefferies reports. “Specifically, TMO's initial 2012 financial outlook contemplates 5%...
-
Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development
Thursday, May 26, 2011 - 8:44am | 60PAREXEL International Corporation (NASDAQ: PRXL) today announced that it has been selected as one of two strategic partners by Pfizer Inc. to provide clinical development services. PAREXEL will work with Pfizer to achieve greater speed and cost efficiencies in its clinical development programs...
-
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
Thursday, May 26, 2011 - 8:35am | 46ICON plc, (NASDAQ: ICLR) today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) which will see it serve as one of two preferred providers of clinical trial implementation services.
-
Benzinga's Top Pre-Market NASDAQ Gainers
Thursday, May 26, 2011 - 8:16am | 147USA Technologies Inc (NASDAQ: USAT) shares advanced 7.59% to $2.55 in the pre-market session. Analysts at initiated Northland Securities initiated coverage of USAT with an “outperform” rating. Level 3 Communications Inc (NASDAQ: LVLT) shares advanced 4.55% to $2.30 in the pre-market session. LVLT...
-
Auriga Reiterates Buy on Thermo Fisher Scientific
Thursday, May 26, 2011 - 8:08am | 186Auriga is out with its report today on Thermo Fisher Scientific (NYSE: TMO), reiterating Buy. In a note to clients, Auriga writes, "Yesterday, Thermo Fisher held a well-attended Analyst Meeting here in New York. Management presented a detailed overview of growth areas of the business, operating...
-
Morgan Stanley Reports on Thermo Fischer Scientific
Thursday, May 26, 2011 - 7:37am | 166Morgan Stanley commented on Thermo Fischer Scientific (NYSE: TMO) in a report released today. In the report, Morgan Stanley was positive in its assessment of the company. Morgan Stanley writes, "The analyst day supports our positive thesis with 1) solid core business trends, 2) improving...
-
Genetic Technologies Files New Patent Infringement Suit in USA
Thursday, May 26, 2011 - 7:20am | 192Genetic Technologies Limited (NASDAQ: GENE) wishes to advise that on May 25, 2011 it filed suit in the U.S. District Court for the District of Colorado, asserting infringement of its primary non-coding patent against the following parties: Agilent Technologies Inc.; Bristol-Myers Squibb Company...
-
AMAG Pharmaceuticals Announces Resignation of CFO
Wednesday, May 25, 2011 - 4:31pm | 49AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that David Arkowitz, AMAG's executive vice president, chief financial officer and chief business officer, has resigned to pursue an opportunity at a private biofuels company. Mr. Arkowitz will remain with AMAG through June 24th.
-
Jefferies Comments on Caliper Life Sciences Following Customer Owners Group Event
Wednesday, May 25, 2011 - 8:24am | 92Jefferies attended Caliper Life Sciences' (NASDAQ: CALP) recent 2011 Customer Owners Group event at its headquarters in Hopkinton, MA last week “where we observed an impressive pedigree of attendees, which included ~350 leading researchers from large pharmaceutical, biotech and well-heeled...